Fangzhou Powers Digital Healthcare with AI | | Large language models chatgpt | Large language models tutorial pdf github | Turtles AI

Fangzhou Inc. has integrated the open-source DeepSeek-R1 model into its digital healthcare platform, improving the accuracy and efficiency of services. The upgrade enhances chronic disease management and decision support for doctors and patients, while ensuring security and privacy.

Key Points:

• AI Integration: DeepSeek-R1 streamlines medical analytics and healthcare management.
• Patient Benefits: Improved interpretation of reports and therapy management.
• Support for Physicians: AI Assistant facilitates diagnosis, prescriptions and treatments.
• Future Innovation: Development of AI Agent for advanced clinical data analysis.

Fangzhou Inc. (06086.HK), a leading digital healthcare company, has officially implemented the open-source AI model DeepSeek-R1, marking a technological evolution in the Internet healthcare landscape. The integration, aimed at strengthening the accuracy of diagnoses and the personalization of treatments, will enable more effective management of clinical data, improving the interaction between patients and healthcare professionals. The strategic decision to adopt DeepSeek-R1 is part of Fangzhou’s vision to enhance its analytical and workflow rationalization capabilities, while maintaining a high standard of security and confidentiality of sensitive information.

The company’s founder, chairman and CEO, Dr. Xie Fangmin, emphasized the importance of this implementation for the future of the company, highlighting the key role of AI in improving the quality and accessibility of care. The use of DeepSeek-R1 allows for the processing of huge amounts of clinical data quickly and intelligently, allowing both patients to receive more targeted care and doctors to optimize the time dedicated to more complex clinical activities.

The adoption of this innovative technology translates into a greater capacity to support the management of chronic diseases, a segment in which Fangzhou boasts a leadership position with 45.6 million registered users and 217,000 active doctors (data updated to June 30, 2024). The AI ​​system enhances the interpretation of diagnostic reports, laboratory results and clinical parameters, offering more accurate indications on treatments and prescriptions.

At the same time, the platform introduces an advanced AI Assistant for healthcare professionals, capable of assisting doctors in evaluating prescriptions, monitoring response to treatments and managing medical records. The DeepSeek-R1 model, thanks to its data-driven reasoning capabilities, also contributes to better processing of therapeutic protocols, supporting the decision-making process with validated scientific evidence.

Looking to the future, Fangzhou has outlined an ambitious development plan focused on the evolution of AI Agents, advanced tools that will exploit the analytical capabilities of DeepSeek-R1 to further refine the processing of clinical information.

The goal is to make digital healthcare increasingly effective, personalized and predictive, consolidating the role of AI as a strategic lever for the progress of healthcare via the Internet.